Digital Phenotyping of High-Risk Chronic Ventilator-Dependent Patients

June 14, 2026 updated by: Huang Xu, China-Japan Friendship Hospital

Multidimensional Digital Phenotyping of High-Risk Chronic Disease Patients With Ventilator Dependence

This project plans to employ a multi-center retrospective and prospective cohort study design. It aims to collect data on ventilator support strategies, duration of invasive mechanical ventilation, incidence of ventilator dependence, high-risk factors for ventilator dependence, and in-hospital mortality rates among different chronic disease populations in the ICU. This will involve combining unstructured data with real-time bedside multi-dimensional high-frequency data (including dynamic changes in data volume, respiratory mechanics, diaphragm ultrasound, EIT, diaphragm electrical activity, and other monitoring parameters) to construct digital phenotypes for chronic disease patients with ventilator dependence and identify high-risk factors for ventilator dependence in this population.

Specifically, the research will:

Utilize an integrated modular intelligent respiratory monitoring system, previously developed by the project team, to achieve dynamic monitoring of multi-dimensional indicators.

Systematically collect dynamic clinical characteristics of mechanical ventilation dependence in chronic disease populations through retrospective and prospective cohort studies, and employ multivariate statistical analysis, machine learning, and other techniques to identify no fewer than 5-6 high-risk factors for ventilator dependence in chronic disease patients.

Establish a data ecosystem suitable for chronic disease patients undergoing mechanical ventilation, build a multi-dimensional high-frequency data platform for chronic ventilator-dependent populations, map the full cycle from intubation to mechanical ventilation support, weaning, and extubation, and construct multidimensional digital phenotypes for high-risk chronic disease patients with ventilator dependence.

Study Overview

Status

Enrolling by invitation

Study Type

Observational

Enrollment (Estimated)

30500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 100029
        • Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Chronic Disease Patients with invasive mechanical ventilation ≥48 hours

Description

Inclusion Criteria:

  • Age > 18 years old.
  • Patients admitted to ICU and receiving invasive mechanical ventilation.
  • Comorbid with chronic diseases.

Exclusion Criteria:

  • Total invasive mechanical ventilation duration ≤ 48 hours.
  • Death within 7 days after ICU admission.
  • Withdrawal of treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients in the Multicenter Retrospective Cohort
Patients in the Multi-Center Prospective Cohort

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of ventilator dependence(mechanical ventilation time≥7 days) in chronic disease patients receiving invasive mechanical ventilation
Time Frame: From enrollment to 7 days
the proportion of patients who achieve sustained liberation from invasive mechanical ventilation within 7 days of the initial intubation.
From enrollment to 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of chronic disease patients still receiving IPPV at 14/21 days after mechanical ventilation
Time Frame: 21 days
the proportion of patients who achieve sustained liberation from invasive mechanical ventilation within 14 and 21 days of the initial intubation.
21 days
Success rate of the first Spontaneous Breathing Trial (SBT) in chronic disease patients
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
Time to first extubation in chronic disease patients
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
Proportion of first extubation failure in chronic disease patients
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
High-risk factors for first extubation failure in chronic disease patients
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
ICU mortality rate
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
In-hospital mortality rate
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
ICU length of stay
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
Total hospital length of stay
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
Duration of invasive mechanical ventilation
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
Incidence of Ventilator-Associated Pneumonia (VAP)
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
Proportion of patients undergoing tracheostomy
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days
Time of tracheostomy
Time Frame: during hospitalization,assessed up to 28 days
among those who receive tracheostomy
during hospitalization,assessed up to 28 days
High-risk factors for ventilator dependence in chronic disease patients
Time Frame: during hospitalization,assessed up to 28 days
during hospitalization,assessed up to 28 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xu Huang, MD, Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2025

Primary Completion (Estimated)

January 1, 2029

Study Completion (Estimated)

January 1, 2029

Study Registration Dates

First Submitted

May 21, 2026

First Submitted That Met QC Criteria

June 14, 2026

First Posted (Actual)

June 18, 2026

Study Record Updates

Last Update Posted (Actual)

June 18, 2026

Last Update Submitted That Met QC Criteria

June 14, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventilator Dependency

Subscribe